These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
210 related items for PubMed ID: 2755453
1. Testing for drugs of abuse in urine. Turk J. Mo Med; 1989 Jun; 86(6):337-40. PubMed ID: 2755453 [Abstract] [Full Text] [Related]
2. More employers are utilizing drug-screening programs. Bitter J. Occup Health Saf; 1990 Apr; 59(4):27-32. PubMed ID: 2336234 [No Abstract] [Full Text] [Related]
4. The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations. Bush DM. Forensic Sci Int; 2008 Jan 30; 174(2-3):111-9. PubMed ID: 17434274 [Abstract] [Full Text] [Related]
5. Current practice and experience in drug and alcohol testing in the workplace. Zwerling C. Bull Narc; 1993 Jan 30; 45(2):155-96. PubMed ID: 7920540 [Abstract] [Full Text] [Related]
6. Research on drugs and the workplace: introduction and summary. Gust SW, Crouch DJ, Walsh JM. NIDA Res Monogr; 1990 Jan 30; 100():3-8. PubMed ID: 2132776 [No Abstract] [Full Text] [Related]
7. Charting the sea of employee addiction. Russo V, Halpern Z. Occup Health Saf; 1992 Dec 30; 61(12):35-6, 65. PubMed ID: 1475070 [No Abstract] [Full Text] [Related]
8. Survey of employer anti-drug programs. Hayghe H. NIDA Res Monogr; 1990 Dec 30; 100():177-207. PubMed ID: 2132771 [No Abstract] [Full Text] [Related]
9. Drug screening in the workplace: use, abuse and implications. Grabowski J, Silverman PB. NIDA Res Monogr; 1989 Dec 30; 95():225-31. PubMed ID: 2640968 [No Abstract] [Full Text] [Related]
10. Drug-free workplace programmes: New Zealand perspective. Nolan S. Forensic Sci Int; 2008 Jan 30; 174(2-3):125-32. PubMed ID: 17467938 [Abstract] [Full Text] [Related]
11. Special report. Drug usage by employees: an update. Hosp Secur Saf Manage; 1992 Jun 30; 13(2):5-9. PubMed ID: 10171055 [Abstract] [Full Text] [Related]
12. Effectiveness and benefit-cost of peer-based workplace substance abuse prevention coupled with random testing. Miller TR, Zaloshnja E, Spicer RS. Accid Anal Prev; 2007 May 30; 39(3):565-73. PubMed ID: 17125723 [Abstract] [Full Text] [Related]
13. The effects of a drug testing program in the Navy. Cangianelli LA. NIDA Res Monogr; 1989 May 30; 95():211-7. PubMed ID: 2640966 [No Abstract] [Full Text] [Related]
14. Substance abuse in the workplace: epidemiology, effects, and industry response. Bush DM, Autry JH. Occup Med; 2002 May 30; 17(1):13-25, iii. PubMed ID: 11726333 [Abstract] [Full Text] [Related]
15. Dealing with substance abuse in the workplace. Malatestinic WN, Jorgenson JA. Hosp Pharm; 1991 Feb 30; 26(2):102-5. PubMed ID: 10170679 [Abstract] [Full Text] [Related]
16. Drug-testing service agencies. Smith RB. Occup Health Saf; 1990 Apr 30; 59(4):33. PubMed ID: 2336235 [No Abstract] [Full Text] [Related]
17. The synergism of health promotion and restoration in the prevention of substance abuse in the workplace. Miller RE, Shain M, Crim D, Golaszewski TJ. Health Values; 1985 Apr 30; 9(5):50-8. PubMed ID: 10317664 [Abstract] [Full Text] [Related]
18. Drugs and alcohol in the workplace. Conry PB. AAOHN J; 1991 Oct 30; 39(10):461-5. PubMed ID: 1930379 [Abstract] [Full Text] [Related]
19. Drug screening in the workplace. A drug awareness/prevention program for hospital settings. Baldwin D. AAOHN J; 1989 Sep 30; 37(9):379-81. PubMed ID: 2775385 [No Abstract] [Full Text] [Related]
20. Occupational health program development. Deeter DP, Prier RE, Schmith JM. Am J Prev Med; 1987 Sep 30; 3(3):128-33. PubMed ID: 3452349 [Abstract] [Full Text] [Related] Page: [Next] [New Search]